Study Design and Treatment
Phase I dose escalation was done using a standard 3 + 3 design. Phase II dose expansion was done using a Simon two-stage design (The study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice Guidelines. The protocol was approved by the Institutional Review Board and all patients provided written informed consent prior to study procedures.